Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics said today that it will offer $150 million of convertible senior notes due 2023 in a private placement to qualified institutional buyers.

The firm also plans to grant the initial purchasers a 13-day option to purchase up to an additional $22.5 million aggregate principal amount of the notes

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.